Targeting vascular smooth muscle cells with natural compounds to combat atherosclerosis

Abstract

Atherosclerosis (AS) is widely recognized as the principal pathological substrate underlying chronic cardiovascular diseases (CVDs). It is a chronic, progressive, and inflammatory disease characterized by excessive lipid deposition, oxidative stress, inflammatory response, plaque formation and rupture, thrombosis and vascular calcification (VC). Vascular smooth muscle cells (VSMCs) are essential for maintaining the normal structure of blood vessels and play a pivotal role in the pathological process of AS. Their proliferation, migration, differentiation, senescence and death processes critically influence the progression of AS. The specific mechanism of VSMCs participating in AS remains a central focus of research in the cardiovascular field. In recent years, natural products have garnered considerable attention in the field of AS prevention and treatment, primarily due to their multi-target effects, low toxicity and side effects. However, there is still a lack of systematic review of natural compounds that alleviate AS by regulating the function of VSMCs. This article focuses on the core role of VSMCs in the progression of AS, and systematically reviews the natural compounds targeting VSMCs metabolism and their molecular regulatory mechanisms. By combing the relevant pharmacological activities and potential targets, the pathological function of VSMCs in AS is further elucidated, thereby providing an important theoretical basis for the development of novel and efficient AS treatment strategies.

Keywords

Cardiovascular disease / Atherosclerosis / Vascular smooth muscle cells / Natural compounds

Funding

This work was supported by the National Key R&D Program of China (No. 2022YFC3500300), Jiangsu Province Traditional Chinese Medicine Science and Technology Development Program (No. QN202426) and the Youth Talent Support Project of the Jiangsu Association for Science and Technology (No. TJ-2023-053).

Declaration of competing interest

There are no conflicts of interest to declare.

References

[1] Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006; 47(8 Suppl):C7-C12. https://doi.org/10.1016/j.jacc.2005.09.068.

[2] Kobiyama K, Ley K. Atherosclerosis. Circ Res. 2018; 123(10):1118-1120. https://doi.org/10.1161/CIRCRESAHA.118.313816.

[3] Pan H, Ho SE, Xue C, et al. Atherosclerosis is a smooth muscle cell—driven tumor—like disease. Circulation. 2024; 149(24):1885-1898. https://doi.org/10.1161/CIRCULATIONAHA.123.067587.

[4] Basatemur GL, Jørgensen HF, Clarke MCH, et al. Vascular smooth muscle cells in atherosclerosis. Nat Rev Cardiol. 2019; 16(12):727-744. https://doi.org/10.1038/s41569—019—0227—9.

[5] Grootaert MOJ, Bennett MR. Vascular smooth muscle cells in atherosclerosis: time for a re—assessment. Cardiovasc Res. 2021; 117(11):2326-2339. https://doi.org/10.1093/cvr/cvab046.

[6] Allahverdian S, Chaabane C, Boukais K, et al. Smooth muscle cell fate and plasticity in atherosclerosis. Cardiovasc Res. 2018; 114(4):540-550. https://doi.org/10.1093/cvr/cvy022.

[7] Grootaert MOJ, Moulis M, Roth L, et al. Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis. Cardiovasc Res. 2018; 114(4):622-634. https://doi.org/10.1093/cvr/cvy007.

[8] Park E, Ito K, Iqbal R, et al. Prospective changes in diastolic function in patients with rheumatoid arthritis. Arthritis Res Ther. 2022; 24(1):184. https://doi.org/10.1186/s13075—022—02864—0.

[9] Wang C, Niimi M, Watanabe T, et al. Treatment of atherosclerosis by traditional Chinese medicine: questions and quandaries. Atherosclerosis. 2018; 277:136-144. https://doi.org/10.1016/j.atherosclerosis.2018.08.039.

[10] Huang H, Song C, Chang J. Synthesis and biological activity study of tanshinone derivatives: a literature and patent review. Curr Top Med Chem. 2020; 20(28):2520-2534. https://doi.org/10.2174/1568026620666200922115109.

[11] Guo R, Li L, Su J, et al. Pharmacological activity and mechanism of tanshinone IIA in related diseases. Drug Des Devel Ther. 2020; 14:4735-4748. https://doi.org/10.2147/DDDT.S266911.

[12] Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995; 75(3):487-517. https://doi.org/10.1152/physrev.1995.75.3.487.

[13] Jones BA, Aly HM, Forsyth EA, et al. Phenotypic characterization of human smooth muscle cells derived from atherosclerotic tibial and peroneal arteries. J Vasc Surg. 1996; 24(5):883-891. https://doi.org/10.1016/S0741—5214(96)70027—7.

[14] Campbell JH, Campbell GR. Smooth muscle phenotypic modulation—a personal experience. Arterioscler Thromb Vasc Biol. 2012; 32(8):1784-1789. https://doi.org/10.1161/ATVBAHA.111.243212.

[15] Zhang DD, Song Y, Kong P, et al. Smooth muscle 22 alpha protein inhibits VSMC foam cell formation by supporting normal LXRα signaling, ameliorating atherosclerosis. Cell Death Dis. 2021; 12(11):982. https://doi.org/10.1038/s41419—021—04239—w.

[16] Orlandi A, Bochaton—Piallat ML, Gabbiani G, et al. Aging, smooth muscle cells and vascular pathobiology: implications for atherosclerosis. Atherosclerosis. 2006; 188(2):221-230. https://doi.org/10.1016/j.atherosclerosis.2006.01.018.

[17] Bashore AC, Chung A, Ibikunle C, et al. Single—cell multimodal profiling of atherosclerosis identifies CD200 as a cell surface lineage marker of vascular smooth muscle cells and their derived cells. Circulation. 2024; 149(15):1231-1233. https://doi.org/10.1161/CIRCULATIONAHA.123.067092.

[18] Liu M, Gomez D. Smooth muscle cell phenotypic diversity. Arterioscler Thromb Vasc Biol. 2019; 39(9):1715-1723. https://doi.org/10.1161/ATVBAHA.119.312131.

[19] Mocci G, Sukhavasi K, Örd T, et al. Single—cell gene—regulatory networks of advanced symptomatic atherosclerosis. Circ Res. 2024; 134(11):1405-1423. https://doi.org/10.1161/CIRCRESAHA.123.323184.

[20] Wirka RC, Wagh D, Paik DT, et al. Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single—cell analysis. Nat Med. 2019; 25(8):1280-1289. https://doi.org/10.1038/s41591—019—0512—5.

[21] Pan H, Xue C, Auerbach BJ, et al. Single—cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human. Circulation. 2020; 142(21):2060-2075. https://doi.org/10.1161/CIRCULATIONAHA.120.048378.

[22] Rong JX, Shapiro M, Trogan E, et al. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage—like state after cholesterol loading. Proc Natl Acad Sci U S A. 2003; 100(23):13531-13536. https://doi.org/10.1073/pnas.1735526100.

[23] Shankman LS, Gomez D, Cherepanova OA, et al. KLF4—dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med. 2015; 21(6):628-637. https://doi.org/10.1038/nm.3866.

[24] Elmarasi M, Elmakaty I, Elsayed B, et al. Phenotypic switching of vascular smooth muscle cells in atherosclerosis, hypertension, and aortic dissection. J Cell Physiol. 2024; 239(4):e31200. https://doi.org/10.1002/jcp.31200.

[25] Hwang AR, Lee HJ, Kim S, et al. Inhibition of p90RSK ameliorates PDGF—BB—ointima. Int J Mol Sci. 2023; 24(9):8094. https://doi.org/10.3390/ijms24098094.

[26] Jiang Y, Qian HY. Transcription factors: key regulatory targets of vascular smooth muscle cell in atherosclerosis. Mol Med. 2023; 29(1):2. https://doi.org/10.1186/s10020—022—00586—2.

[27] Tabas I, García—Cardeña G, Owens GK. Recent insights into the cellular biology of atherosclerosis. J Cell Biol. 2015; 209(1):13-22. https://doi.org/10.1083/jcb.201412052.

[28] Allahverdian S, Chehroudi AC, McManus BM, et al. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage—like cells in human atherosclerosis. Circulation. 2014; 129(15):1551-1559. https://doi.org/10.1161/CIRCULATIONAHA.113.005015.

[29] Chen R, McVey DG, Shen D, et al. Phenotypic switching of vascular smooth muscle cells in atherosclerosis. J Am Heart Assoc. 2023; 12(20):e031121. https://doi.org/10.1161/JAHA.123.031121.

[30] Naik V, Leaf EM, Hu JH, et al. Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study. Cardiovasc Res. 2012; 94(3):545-554. https://doi.org/10.1093/cvr/cvs126.

[31] Durham AL, Speer MY, Scatena M, et al. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness. Cardiovasc Res. 2018; 114(4):590-600. https://doi.org/10.1093/cvr/cvy010.

[32] Lee SJ, Lee IK, Jeon JH. Vascular calcification—new insights into its mechanism. Int J Mol Sci. 2020; 21(8):2685. https://doi.org/10.3390/ijms21082685.

[33] Hu CT, Shao YD, Liu YZ, et al. Oxidative stress in vascular calcification. Clin Chim Acta. 2021; 519:101-110. https://doi.org/10.1016/j.cca.2021.04.012.

[34] Shanahan CM, Cary NR, Metcalfe JC, et al. High expression of genes for calcification—regulating proteins in human atherosclerotic plaques. J Clin Invest. 1994; 93(6):2393-2402. https://doi.org/10.1172/JCI117246.

[35] Shi J, Yang Y, Cheng A, et al. Metabolism of vascular smooth muscle cells in vascular diseases. Am J Physiol Heart Circ Physiol. 2020; 319(3):H613-H631. https://doi.org/10.1152/ajpheart.00220.2020.

[36] Long JZ, Svensson KJ, Tsai L, et al. A smooth muscle—like origin for beige adipocytes. Cell Metab. 2014; 19(5):810-820. https://doi.org/10.1016/j.cmet.2014.03.025.

[37] Davies JD, Carpenter KL, Challis IR, et al. Adipocytic differentiation and liver X receptor pathways regulate the accumulation of triacylglycerols in human vascular smooth muscle cells. J Biol Chem. 2005; 280(5):3911-3919. https://doi.org/10.1074/jbc.M410075200.

[38] Adachi Y, Ueda K, Nomura S, et al. Beiging of perivascular adipose tissue regulates its inflammation and vascular remodeling. Nat Commun. 2022; 13(1):5117. https://doi.org/10.1038/s41467—022—32658—6.

[39] Nguyen DCA, Briones AM, Callera GE, et al. Adipocyte—derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors. Hypertension. 2011; 58(3):479-488. https://doi.org/10.1161/HYPERTENSIONAHA.110.168872.

[40] Riascos—Bernal DF, Ressa G, Korrapati A, et al. The FAT1 cadherin drives vascular smooth muscle cell migration. Cells. 2023;12(12):1621. https://doi.org/10.3390/cells12121621.

[41] Davies MJ, Richardson PD, Woolf N, et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993; 69(5):377-381. https://doi.org/10.1136/hrt.69.5.377.

[42] Zernecke A. CD98 promotes vascular smooth muscle cell accumulation in atherosclerosis to confer plaque stability. Atherosclerosis. 2017; 256:128-130. https://doi.org/10.1016/j.atherosclerosis.2016.11.028.

[43] Yurdagul AJ. Crosstalk between macrophages and vascular smooth muscle cells in atherosclerotic plaque stability. Arterioscler Thromb Vasc Biol. 2022; 42(4):372-380. https://doi.org/10.1161/ATVBAHA.121.316233.

[44] Nelson AR, Fingleton B, Rothenberg ML, et al. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol. 2000; 18(5):1135-1149. https://doi.org/10.1200/JCO.2000.18.5.1135.

[45] Newby AC. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non—matrix substrates. Cardiovasc Res. 2006; 69(3):614-624. https://doi.org/10.1016/j.cardiores.2005.08.002.

[46] Braun—Dullaeus RC, Mann MJ, Dzau VJ. Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation. 1998; 98(1):82-89. https://doi.org/10.1161/01.CIR.98.1.82.

[47] Hofbauer R, Denhardt DT. Cell cycle—regulated and proliferation stimulus—responsive genes. Crit Rev Eukaryot Gene Expr. 1991; 1(4):247-300.

[48] Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995; 95(5):2266-2274. https://doi.org/10.1172/JCI117917.

[49] Bennett MR, Macdonald K, Chan SW, et al. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res. 1998; 82(6):704-712. https://doi.org/10.1161/01.RES.82.6.704.

[50] Mahmoudi M, Gorenne I, Mercer J, et al. Statins use a novel Nijmegen breakage syndrome—1—dependent pathway to accelerate DNA repair in vascular smooth muscle cells. Circ Res. 2008; 103(7):717-725. https://doi.org/10.1161/CIRCRESAHA.108.182899.

[51] Bredesen DE. Neural apoptosis. Ann Neurol. 1995; 38(6):839-851. https://doi.org/10.1002/ana.410380604.

[52] Li M, Wang ZW, Fang LJ, et al. Programmed cell death in atherosclerosis and vascular calcification. Cell Death Dis. 2022; 13(5):467. https://doi.org/10.1038/s41419—022—04923—5.

[53] Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011; 147(4):728-741. https://doi.org/10.1016/j.cell.2011.10.026.

[54] Martinet W, de Meyer GR. Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ Res. 2009; 104(3):304-317. https://doi.org/10.1161/CIRCRESAHA.108.188318.

[55] Kiffin R, Bandyopadhyay U, Cuervo AM. Oxidative stress and autophagy. Antioxid Redox Signal. 2006; 8(1—2):152-162. https://doi.org/10.1089/ars.2006.8.152.

[56] Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010; 464(7293):1357-1361. https://doi.org/10.1038/nature08938.

[57] Zachari M, Ganley IG. The mammalian ULK1 complex and autophagy initiation. Essays Biochem. 2017; 61(6):585-596. https://doi.org/10.1042/EBC20170021.

[58] Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011; 13(2):132-141. https://doi.org/10.1038/ncb2152.

[59] Grootaert MO, da Costa MPA, Bitsch N, et al. Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis. Autophagy. 2015;11(11):2014-2032. https://doi.org/10.1080/15548627.2015.1096485.

[60] Salabei JK, Hill BG. Implications of autophagy for vascular smooth muscle cell function and plasticity. Free Radic Biol Med. 2013; 65:693-703. https://doi.org/10.1016/j.freeradbiomed.2013.08.003.

[61] Salabei JK, Cummins TD, Singh M, et al. PDGF—mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress. Biochem J. 2013; 451(3):375-388. https://doi.org/10.1042/BJ20121344.

[62] Li J, Zhao L, Yang T, et al. c—Ski inhibits autophagy of vascular smooth muscle cells induced by oxLDL and PDGF. PLoS One. 2014; 9(6):e98902. https://doi.org/10.1371/journal.pone.0098902.

[63] Li H, Li J, Li Y, et al. Sonic hedgehog promotes autophagy of vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2012; 303(11):H1319-H1331. https://doi.org/10.1152/ajpheart.00160.2012.

[64] García—Miguel M, Riquelme JA, Norambuena—Soto I, et al. Autophagy mediates tumor necrosis factor—α—induced phenotype switching in vascular smooth muscle A7r5 cell line. PLoS One. 2018; 13(5):e0197210. https://doi.org/10.1371/journal.pone.0197210.

[65] Shan R, Liu N, Yan Y, et al. Apoptosis, autophagy and atherosclerosis: relationships and the role of Hsp27. Pharmacol Res. 2021; 166:105169. https://doi.org/10.1016/j.phrs.2020.105169.

[66] Zeng ZL, Li GH, Wu SY, et al. Role of pyroptosis in cardiovascular disease. Cell Prolif. 2019; 52(2):e12563. https://doi.org/10.1111/cpr.12563.

[67] Yin Z, Zhang J, Shen Z, et al. Regulated vascular smooth muscle cell death in vascular diseases. Cell Prolif. 2024; 57(11):e13688. https://doi.org/10.1111/cpr.13688.

[68] Pan J, Han L, Guo J, et al. AIM2 accelerates the atherosclerotic plaque progressions in ApoE−/− mice. Biochem Biophys Res Commun. 2018; 498(3):487-494. https://doi.org/10.1016/j.bbrc.2018.03.005.

[69] Li Y, Niu X, Xu H, et al. VX—765 attenuates atherosclerosis in ApoE deficient mice by modulating VSMCs pyroptosis. Exp Cell Res. 2020; 389(1):111847. https://doi.org/10.1016/j.yexcr.2020.111847.

[70] Zhou Y, Zhou H, Hua L, et al. Verification of ferroptosis and pyroptosis and identification of PTGS2 as the hub gene in human coronary artery atherosclerosis. Free Radic Biol Med. 2021; 171:55-68. https://doi.org/10.1016/j.freeradbiomed.2021.05.009.

[71] Shimada K, Skouta R, Kaplan A, et al. Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat Chem Biol. 2016; 12(7):497-503. https://doi.org/10.1038/nchembio.2079.

[72] Zhang Y, Swanda RV, Nie L, et al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat Commun. 2021; 12(1):1589. https://doi.org/10.1038/s41467—021—21841—w.

[73] Zhang S, Bei Y, Huang Y, et al. Induction of ferroptosis promotes vascular smooth muscle cell phenotypic switching and aggravates neointimal hyperplasia in mice. Mol Med. 2022; 28(1):121. https://doi.org/10.1186/s10020—022—00549—7.

[74] Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet—derived growth factor. Physiol Rev. 1999; 79(4):1283-1316. https://doi.org/10.1152/physrev.1999.79.4.1283.

[75] Zhan Y, Kim S, Izumi Y, et al. Role of JNK, p38, and ERK in platelet—derived growth factor—induced vascular proliferation, migration, and gene expression. Arterioscler Thromb Vasc Biol. 2003; 23(5):795-801. https://doi.org/10.1161/01.ATV.0000066132.32063.F2.

[76] Seger R, Krebs EG. The MAPK signaling cascade. FASEB J. 1995;9(9):726-735. https://doi.org/10.1096/fasebj.9.9.7601337.

[77] Bonizzi G, Karin M. The two NF—κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004; 25(6):280-288. https://doi.org/10.1016/j.it.2004.03.008.

[78] Li ZW, Chu W, Hu Y, et al. The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis. J Exp Med. 1999; 189(11):1839-1845. https://doi.org/10.1084/jem.189.11.1839.

[79] Wang J, Hu K, Cai X, et al. Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharm Sin B. 2022; 12(1):18-32. https://doi.org/10.1016/j.apsb.2021.07.023.

[80] Li QY, Chen L, Fu WH, et al. Ginsenoside Rb1 inhibits proliferation and inflammatory responses in rat aortic smooth muscle cells. J Agric Food Chem. 2011; 59(11):6312-6318. https://doi.org/10.1021/jf200424k.

[81] Huynh DTN, Jin Y, Van Nguyen D, et al. Ginsenoside Rh1 inhibits angiotensin II—induced vascular smooth muscle cell migration and proliferation through suppression of the ROS—mediated ERK1/2/p90RSK/KLF4 signaling pathway. Antioxidants (Basel). 2022; 11(4):643. https://doi.org/10.3390/antiox11040643.

[82] Moon CY, Ku CR, Cho YH, et al. Protocatechuic aldehyde inhibits migration and proliferation of vascular smooth muscle cells and intravascular thrombosis. Biochem Biophys Res Commun. 2012; 423(1):116-121. https://doi.org/10.1016/j.bbrc.2012.05.092.

[83] Wang K, Wen L, Peng W, et al. Vinpocetine attenuates neointimal hyperplasia in diabetic rat carotid arteries after balloon injury. PLoS One. 2014; 9(5):e96894. https://doi.org/10.1371/journal.pone.0096894.

[84] Li W, Yu J, Xiao X, et al. The inhibitory effect of (−)—epicatechin gallate on the proliferation and migration of vascular smooth muscle cells weakens and stabilizes atherosclerosis. Eur J Pharmacol. 2021; 891:173761. https://doi.org/10.1016/j.ejphar.2020.173761.

[85] Yu J, Song H, Zhou L, et al. (−)—Epicatechin gallate prevented atherosclerosis by reducing abnormal proliferation of VSMCs and oxidative stress of AML12 cells. Cell Signal. 2024; 121:111276. https://doi.org/10.1016/j.cellsig.2024.111276.

[86] Lin HC, Hsieh MJ, Peng CH, et al. Pterostilbene inhibits vascular smooth muscle cells migration and matrix metalloproteinase—2 through modulation of MAPK pathway. J Food Sci. 2015; 80(10):H2331-H2335. https://doi.org/10.1111/1750—3841.13002.

[87] Luo L, Liang H, Liu L. Myristicin regulates proliferation and apoptosis in oxidized low—density lipoprotein—stimulated human vascular smooth muscle cells and human umbilical vein endothelial cells by regulating the PI3K/Akt/NF—κB signalling pathway. Pharm Biol. 2022; 60(1):56-64. https://doi.org/10.1080/13880209.2021.2010775.

[88] Zha Y, Yang Y, Zhou Y, et al. Dietary evodiamine inhibits atherosclerosis—associated changes in vascular smooth muscle cells. Int J Mol Sci. 2023; 24(7):6653. https://doi.org/10.3390/ijms24076653.

[89] Yang TY, Wu YL, Yu MH, et al. Mulberry leaf and neochlorogenic acid alleviates glucolipotoxicity—induced oxidative stress and inhibits proliferation/migration via downregulating Ras and FAK signaling pathway in vascular smooth muscle cell. Nutrients. 2022; 14(15):3006. https://doi.org/10.3390/nu14153006.

[90] Li S, Cheng L, An D, et al. Whitmania Pigra whitman extracts inhibit lipopolysaccharide induced rat vascular smooth muscle cells migration and their adhesion ability to THP—1 and RAW 264.7 cells. J Atheroscler Thromb. 2017; 24(3):301-311. https://doi.org/10.5551/jat.36558.

[91] Hsuan CF, Lu yc, Tsai IT, et al. Glossogyne tenuifolia attenuates proliferation and migration of vascular smooth muscle cells. Molecules. 2020; 25(24):5832. https://doi.org/10.3390/molecules25245832.

[92] Zhang J, Zhao WR, Shi WT, et al. Tribulus terrestris L. extract ameliorates atherosclerosis by inhibition of vascular smooth muscle cell proliferation in ApoE−/− mice and A7r5 cells via suppression of Akt/MEK/ERK signaling. J Ethnopharmacol. 2022; 297:115547. https://doi.org/10.1016/j.jep.2022.115547.

[93] Wu Y, Chen M, Chen Z, et al. Theaflavin—3,3'—digallate from black tea inhibits neointima formation through suppression of the PDGFRβ pathway in vascular smooth muscle cells. Front Pharmacol. 2022; 13:861319. https://doi.org/10.3389/fphar.2022.861319.

[94] Fan S, Wang C, Huang K, et al. Myricanol inhibits platelet derived growth factor—BB—induced vascular smooth muscle cells proliferation and migration in vitro and intimal hyperplasia in vivo by targeting the platelet—derived growth factor receptor—β and NF—κB signaling. Front Physiol. 2022; 12:790345. https://doi.org/10.3389/fphys.2021.790345.

[95] Lee JH, Kim MJ, Woo KJ, et al. Evening primrose extracts inhibit PDGF—BB—induced vascular smooth muscle cell proliferation and migration by regulating cell—cycle—related proteins. Curr Issues Mol Biol. 2022; 44(5):1928-1940. https://doi.org/10.3390/cimb44050131.

[96] Lee GL, Wu JY, Tsai CS, et al. TLR4—activated MAPK—IL—6 axis regulates vascular smooth muscle cell function. Int J Mol Sci. 2016; 17(9):1394. https://doi.org/10.3390/ijms17091394.

[97] Curtiss LK, Tobias PS. Emerging role of Toll—like receptors in atherosclerosis. J Lipid Res. 2009; 50(Suppl):S340-S345. https://doi.org/10.1194/jlr.R800056—JLR200.

[98] Wang Y, Li Y, Chen Y, et al. Corilagin relieves atherosclerosis via the toll—like receptor 4 signaling pathway in vascular smooth muscle cells. Int J Immunopathol Pharmacol. 2024; 38:3946320241254083. https://doi.org/10.1177/03946320241254083.

[99] Wu X, Hu Z, Zhou J, et al. Ferulic acid alleviates atherosclerotic plaques by inhibiting VSMC proliferation through the NO/p21 signaling pathway. J Cardiovasc Transl Res. 2022; 15(4):865-875. https://doi.org/10.1007/s12265—021—10196—8.

[100] Song Y, Long L, Zhang N, et al. Inhibitory effects of hydroxysafflor yellow A on PDGF—BB—induced proliferation and migration of vascular smooth muscle cells via mediating Akt signaling. Mol Med Rep. 2014; 10(3):1555-1560. https://doi.org/10.3892/mmr.2014.2336.

[101] Gao Y, Zhu P, Xu SF, et al. Ginsenoside Re inhibits PDGF—BB—induced VSMC proliferation via the eNOS/NO/cGMP pathway. Biomed Pharmacother. 2019; 115:108934. https://doi.org/10.1016/j.biopha.2019.108934.

[102] Banerjee S, Biehl A, Gadina M, et al. JAK—STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs. 2017; 77(5):521-546. https://doi.org/10.1007/s40265—017—0701—9.

[103] Huang Q, Liu X, Yu J, et al. Schisandrin inhibits VSMCs proliferation and migration by arresting cell cycle and targeting JAK2 to regulating the JAK2/STAT3 pathway. Tissue Cell. 2024; 89:102440. https://doi.org/10.1016/j.tice.2024.102440.

[104] Wu Q, Wang W, Li S, et al. American ginseng inhibits vascular smooth muscle cell proliferation via suppressing Jak/Stat pathway. J Ethnopharmacol. 2012; 144(3):782-785. https://doi.org/10.1016/j.jep.2012.09.046.

[105] Wang H, Wei Z, Li H, et al. MiR—377—3p inhibits atherosclerosis—associated vascular smooth muscle cell proliferation and migration via targeting neuropilin2. Biosci Rep. 2020; 40(6):BSR20193425. https://doi.org/10.1042/BSR20193425.

[106] Sun D, Xiang G, Wang J, et al. miRNA 146b—5p protects against atherosclerosis by inhibiting vascular smooth muscle cell proliferation and migration. Epigenomics. 2020; 12(24):2189-2204. https://doi.org/10.2217/epi—2020—0155.

[107] Huang P, Wang F, Zhang Y, et al. Icariin alleviates atherosclerosis by regulating the miR—205—5p/ERBB4/AKT signaling pathway. Int Immunopharmacol. 2023; 114:109611. https://doi.org/10.1016/j.intimp.2022.109611.

[108] Li J, Li Y, Yuan X, et al. The effective constituent puerarin, from Pueraria lobata, inhibits the proliferation and inflammation of vascular smooth muscle in atherosclerosis through the miR—29b—3p/IGF1 pathway. Pharm Biol. 2023; 61(1):1-11. https://doi.org/10.1080/13880209.2022.2099430.

[109] Li Y, Chen F, Guo R, et al. Tanshinone ΙΙA inhibits homocysteine—induced proliferation of vascular smooth muscle cells via miR—145/CD40 signaling. Biochem Biophys Res Commun. 2020; 522(1):157-163. https://doi.org/10.1016/j.bbrc.2019.11.055.

[110] Zhang M, Li F, Pokharel S, et al. Lycium barbarum polysaccharide protects against homocysteine—induced vascular smooth muscle cell proliferation and phenotypic transformation via PI3K/Akt pathway. J Mol Histol. 2020; 51(6):629-637. https://doi.org/10.1007/s10735—020—09909—1.

[111] Chung DJ, Wu YL, Yang MY, et al. Nelumbo nucifera leaf polyphenol extract and gallic acid inhibit TNF—α—induced vascular smooth muscle cell proliferation and migration involving the regulation of miR—21, miR—143 and miR—145. Food Funct. 2020; 11(10):8602-8611. https://doi.org/10.1039/d0fo02135k.

[112] Wang K, Zhou Z, Zhang M, et al. Peroxisome proliferator—activated receptor gamma down—regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model. J Pharmacol Exp Ther. 2006; 317(1):37-43. https://doi.org/10.1124/jpet.105.095125.

[113] Hsueh WA, Jackson S, Law RE. Control of vascular cell proliferation and migration by PPAR—gamma: a new approach to the macrovascular complications of diabetes. Diabetes Care. 2001; 24(2):392-397. https://doi.org/10.2337/diacare.24.2.392.

[114] Guo M, Guo G, Xiao J, et al. Ginsenoside Rg3 stereoisomers differentially inhibit vascular smooth muscle cell proliferation and migration in diabetic atherosclerosis. J Cell Mol Med. 2018; 22(6):3202-3214. https://doi.org/10.1111/jcmm.13601.

[115] Panthiya L, Tocharus J, Chaichompoo W, et al. Hexahydrocurcumin mitigates angiotensin II—induced proliferation, migration, and inflammation in vascular smooth muscle cells. EXCLI J. 2023; 22:466-481. https://doi.org/10.17179/excli2023—6124.

[116] Guo HY, Lu ZY, Zhao B, et al. Effects of Bunao—Fuyuan Decoction serum on proliferation and migration of vascular smooth muscle cells in atherosclerotic. Chin J Nat Med. 2021; 19(1):36-45. https://doi.org/10.1016/S1875—5364(21)60004—3.

[117] Lu Q, Hong W. Bcl2 enhances c—Myc—mediated MMP—2 expression of vascular smooth muscle cells. Cell Signal. 2009; 21(7):1054-1059. https://doi.org/10.1016/j.cellsig.2009.02.020.

[118] Luo Z, Deng H, Fang Z, et al. Ligustilide inhibited rat vascular smooth muscle cells migration via c—Myc/MMP2 and ROCK/JNK signaling pathway. J Food Sci. 2019; 84(12):3573-3583. https://doi.org/10.1111/1750—3841.14936.

[119] Chen CP, Wu YL, Chan KC, et al. Mulberry polyphenols ameliorate atherogenic migration and proliferation by degradation of K—Ras and downregulation of its signals in vascular smooth muscle cell. Int J Med Sci. 2022; 19(10):1557-1566. https://doi.org/10.7150/ijms.76006.

[120] Hao Y, Baker D, Ten Dijke P. TGF—β—mediated epithelial—mesenchymal transition and cancer metastasis. Int J Mol Sci. 2019; 20(11):2767. https://doi.org/10.3390/ijms20112767.

[121] Derynck R, Budi EH. Specificity, versatility, and control of TGF—β family signaling. Sci Signal. 2019; 12(570):eaav5183. https://doi.org/10.1126/scisignal.aav5183.

[122] Zhou Y, Little PJ, Xu S, et al. Curcumin inhibits lysophosphatidic acid mediated MCP—1 expression via blocking ROCK signalling. Molecules. 2021; 26(8):2320. https://doi.org/10.3390/molecules26082320.

[123] Chen G, Xu H, Wu Y, et al. Myricetin suppresses the proliferation and migration of vascular smooth muscle cells and inhibits neointimal hyperplasia via suppressing TGFBR1 signaling pathways. Phytomedicine. 2021; 92:153719. https://doi.org/10.1016/j.phymed.2021.153719.

[124] Sasaki Y, Ikeda Y, Miyauchi T, et al. Estrogen—SIRT1 axis plays a pivotal role in protecting arteries against menopause—induced senescence and atherosclerosis. J Atheroscler Thromb. 2020; 27(1):47-59. https://doi.org/10.5551/jat.47993.

[125] Yuan L, Wang D, Wu C. Protective effect of liquiritin on coronary heart disease through regulating the proliferation of human vascular smooth muscle cells via upregulation of sirtuin1. Bioengineered. 2022; 13(2):2840-2850. https://doi.org/10.1080/21655979.2021.2024687.

[126] He JH, Li XJ, Wang SP, et al. Eugenol inhibits Ox—LDL—induced proliferation and migration of human vascular smooth muscle cells by inhibiting the Ang II/MFG—E8/MCP—1 signaling cascade. J Inflamm Res. 2024; 17:641-653. https://doi.org/10.2147/JIR.S446960.

[127] He Y, Wang R, Zhang P, et al. Curcumin inhibits the proliferation and migration of vascular smooth muscle cells by targeting the chemerin/CMKLR1/LCN2 axis. Aging (Albany NY). 2021; 13(10):13859-13875. https://doi.org/10.18632/aging.202980.

[128] Huo YB, Gao X, Peng Q, et al. Dihydroartemisinin alleviates Ang II—induced vascular smooth muscle cell proliferation and inflammatory response by blocking the FTO/NR4A3 axis. Inflamm Res. 2022; 71(2):243-253. https://doi.org/10.1007/s00011—021—01533—3.

[129] Lee JJ, Yi H, Kim IS, et al. (2S)—naringenin from Typha angustata inhibits vascular smooth muscle cell proliferation via a G0/G1 arrest. J Ethnopharmacol. 2012; 139(3):873-878. https://doi.org/10.1016/j.jep.2011.12.038.

[130] Gubanova E, Issaeva N, Gokturk C, et al. SMG—1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways. Cell Cycle. 2013; 12(24):3770-3780. https://doi.org/10.4161/cc.26660.

[131] Zhang DQ, Li JS, Zhang YM, et al. Astragaloside IV inhibits angiotensin II—stimulated proliferation of rat vascular smooth muscle cells via the regulation of CDK2 activity. Life Sci. 2018; 200:105-109. https://doi.org/10.1016/j.lfs.2018.03.036.

[132] Lin HH, Hsieh MC, Wang CP, et al. Anti—atherosclerotic effect of gossypetin on abnormal vascular smooth muscle cell proliferation and migration. Antioxidants (Basel). 2021; 10(9):1357. https://doi.org/10.3390/antiox10091357.

[133] Hou L, Zou Z, Wang Y, et al. Exploring the anti—atherosclerosis mechanism of ginsenoside Rb1 by integrating network pharmacology and experimental verification. Aging (Albany NY). 2024; 16(8):6745-6756. https://doi.org/10.18632/aging.205680.

[134] Kahl CR, Means AR. Regulation of cell cycle progression by calcium/calmodulin—dependent pathways. Endocr Rev. 2003; 24(6):719-736. https://doi.org/10.1210/er.2003—0008.

[135] Ginty DD. Calcium regulation of gene expression: isn’t that spatial? Neuron. 1997; 18(2):183-186. https://doi.org/10.1016/S0896—6273(00)80258—5.

[136] Graef IA, Chen F, Chen L, et al. Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell. 2001; 105(7):863-875. https://doi.org/10.1016/S0092—8674(01)00396—8.

[137] Xiao M, Xian C, Wang Y, et al. Nuciferine attenuates atherosclerosis by regulating the proliferation and migration of VSMCs through the Calm4/MMP12/AKT pathway in ApoE(−/−) mice fed with high—fat—diet. Phytomedicine. 2023; 108:154536. https://doi.org/10.1016/j.phymed.2022.154536.

[138] Zhang W, Zhang L, Zhang X. Anti—atherosclerotic effects of genistein in preventing ox—low—density lipoprotein—induced smooth muscle—derived foam cell formation via inhibiting SRC expression and L—Ca channel currents. Ann Transl Med. 2022; 10(12):700. https://doi.org/10.21037/atm—22—2113.

[139] Qi J, Cui J, Mi B, et al. Isoliquiritigenin inhibits atherosclerosis by blocking TRPC5 channel expression. Cardiovasc Ther. 2020; 2020:1926249. https://doi.org/10.1155/2020/1926249.

[140] Byon CH, Javed A, Dai Q, et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem. 2008; 283(22):15319-15327. https://doi.org/10.1074/jbc.M800021200.

[141] Tang FT, Chen SR, Wu XQ, et al. Hypercholesterolemia accelerates vascular calcification induced by excessive vitamin D via oxidative stress. Calcif Tissue Int. 2006; 79(5):326-339. https://doi.org/10.1007/s00223—006—0004—8.

[142] Iacobini C, Fassino V, Mazzaferro S, et al. In vitro evaluation of the calcification inhibitory properties of policosanol, genistein, and vitamin D (Reduplaxin®) either alone or in combination. Kidney Blood Press Res. 2024; 49(1):137-143. https://doi.org/10.1159/000535810.

[143] Zheng G, Zhao Y, Li Z, et al. GLSP and GLSP—derived triterpenes attenuate atherosclerosis and aortic calcification by stimulating ABCA1/G1—mediated macrophage cholesterol efflux and inactivating RUNX2—mediated VSMC osteogenesis. Theranostics. 2023; 13(4):1325-1341. https://doi.org/10.7150/thno.80250.

[144] Pei YQ, Zheng YQ, Ding YD, et al. Triptolide attenuates vascular calcification by upregulating expression of miRNA—204. Front Pharmacol. 2020; 11:581230. https://doi.org/10.3389/fphar.2020.581230.

[145] Li Q, Zhou Q, Li S, et al. Target analysis and identification of curcumin against vascular calcification. Sci Rep. 2024; 14(1):17344. https://doi.org/10.1038/s41598—024—67776—2.

[146] Zhong H, Li DY, Wang SY, et al. Tanshinone IIA attenuates vascular calcification through inhibition of NF—κB and β—catenin signaling pathways. Acta Physiol Sin. 2022; 74(6):949-958. https://doi.org/10.13294/j.aps.2022.0086.

[147] Liou SF, Nguyen TTN, Hsu JH, et al. The preventive effects of xanthohumol on vascular calcification induced by vitamin D(3) plus nicotine. Antioxidants (Basel). 2020; 9(10):956. https://doi.org/10.3390/antiox9100956.

[148] Sulistyowati E, Hsu JH, Lee SJ, et al. Potential actions of baicalein for preventing vascular calcification of smooth muscle cells in vitro and in vivo. Int J Mol Sci. 2022; 23(10):5673. https://doi.org/10.3390/ijms23105673.

[149] Wei X, Shen Z, Zhu M, et al. The pterostilbene—dihydropyrazole derivative Ptd—1 ameliorates vascular calcification by regulating inflammation. Int Immunopharmacol. 2023; 125(Pt B):111198. https://doi.org/10.1016/j.intimp.2023.111198.

[150] Cui X, Zhang L, Lin L, et al. Notoginsenoside R1—protocatechuic aldehyde reduces vascular inflammation and calcification through increasing the release of nitric oxide to inhibit TGFβR1—YAP/TAZ pathway in vascular smooth muscle cells. Int Immunopharmacol. 2024; 143(Pt 3):113574. https://doi.org/10.1016/j.intimp.2024.113574.

[151] Du H, Zhao Q, Zang H, et al. Artemisinin attenuates the development of atherosclerotic lesions by the regulation of vascular smooth muscle cell phenotype switching. Life Sci. 2019; 237:116943. https://doi.org/10.1016/j.lfs.2019.116943.

[152] Sun SY, Cao YM, Huo YJ, et al. Nicotinate—curcumin inhibits Ang II—induced vascular smooth muscle cell phenotype switching by upregulating Daxx expression. Cell Adh Migr. 2021; 15(1):116-125. https://doi.org/10.1080/19336918.2021.1909899.

[153] Zhao L, Cai H, Tang Z, et al. Matrine suppresses advanced glycation end products—induced human coronary smooth muscle cells phenotype conversion by regulating endoplasmic reticulum stress—dependent Notch signaling. Eur J Pharmacol. 2020; 882:173257. https://doi.org/10.1016/j.ejphar.2020.173257.

[154] Meng Q, Yu X, Chen Q, et al. Liuwei Dihuang Soft Capsules inhibits the phenotypic conversion of VSMC to prevent the menopausal atherosclerosis by up—regulating the expression of myocardin. J Ethnopharmacol. 2020; 246:112207. https://doi.org/10.1016/j.jep.2019.112207.

[155] Xiang L, Wang Y, Liu S, et al. Quercetin attenuates KLF4—mediated phenotypic switch of VSMCs to macrophage—like cells in atherosclerosis: a critical role for the JAK2/STAT3 pathway. Int J Mol Sci. 2024; 25(14):7755. https://doi.org/10.3390/ijms25147755.

[156] Li Y, Qin R, Yan H, et al. Inhibition of vascular smooth muscle cells premature senescence with rutin attenuates and stabilizes diabetic atherosclerosis. J Nutr Biochem. 2018; 51:91-98. https://doi.org/10.1016/j.jnutbio.2017.09.012.

[157] Zhou M, Ma X, Gao M, et al. Paeonol attenuates atherosclerosis by inhibiting vascular smooth muscle cells senescence via SIRT1/P53/TRF2 signaling pathway. Molecules. 2024; 29(1):261. https://doi.org/10.3390/molecules29010261.

[158] Liu K, Czaja MJ. Regulation of lipid stores and metabolism by lipophagy. Cell Death Differ. 2013; 20(1):3-11. https://doi.org/10.1038/cdd.2012.63.

[159] Ouimet M, Franklin V, Mak E, et al. Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell Metab. 2011; 13(6):655-667. https://doi.org/10.1016/j.cmet.2011.03.023.

[160] Zuo J, Guo S, Qin X. Bisdemethoxycurcumin suppresses the progression of atherosclerosis and VSMC—derived foam cell formation by promoting lipophagy. Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(12):3659-3670. https://doi.org/10.1007/s00210—023—02558—7.

[161] Gao WC, Yang TH, Wang BB, et al. Scutellarin inhibits oleic acid induced vascular smooth muscle foam cell formation via activating autophagy and inhibiting NLRP3 inflammasome activation. Clin Exp Pharmacol Physiol. 2024; 51(4):e13845. https://doi.org/10.1111/1440—1681.13845.

[162] Shi Y, Jiang S, Zhao T, et al. Celastrol suppresses lipid accumulation through LXRα/ABCA1 signaling pathway and autophagy in vascular smooth muscle cells. Biochem Biophys Res Commun. 2020; 532(3):466-474. https://doi.org/10.1016/j.bbrc.2020.08.076.

[163] Wang G, Zhu Y, Li K, et al. Curcumin—mediated photodynamic therapy inhibits the phenotypic transformation, migration, and foaming of oxidized low—density lipoprotein—treated vascular smooth muscle cells by promoting autophagy. J Cardiovasc Pharmacol. 2021; 78(2):308-318. https://doi.org/10.1097/FJC.0000000000001069.

[164] Pi S, Mao L, Chen J, et al. The P2RY12 receptor promotes VSMC—derived foam cell formation by inhibiting autophagy in advanced atherosclerosis. Autophagy. 2021; 17(4):980-1000. https://doi.org/10.1080/15548627.2020.1741202.

[165] Bao Y, Zhu L, Wang Y, et al. Gualou—Xiebai herb pair and its active ingredients act against atherosclerosis by suppressing VSMC—derived foam cell formation via regulating P2RY12—mediated lipophagy. Phytomedicine. 2024; 128:155341. https://doi.org/10.1016/j.phymed.2024.155341.

[166] Lin J, Gu M, Wang X, et al. Huanglian Jiedu Decoction inhibits vascular smooth muscle cell—derived foam cell formation by activating autophagy via suppressing P2RY12. J Ethnopharmacol. 2024; 328:118125. https://doi.org/10.1016/j.jep.2024.118125.

[167] Zhou Z, Li Y, Jiang W, et al. Molecular mechanism of calycosin inhibited vascular calcification. Nutrients. 2023; 16(1):99. https://doi.org/10.3390/nu16010099.

[168] He HQ, Law BYK, Zhang N, et al. Bavachin protects human aortic smooth muscle cells against β—glycerophosphate—mediated vascular calcification and apoptosis via activation of mTOR—dependent autophagy and suppression of β—catenin signaling. Front Pharmacol. 2019; 10:1427. https://doi.org/10.3389/fphar.2019.01427.

[169] Yu X, Xu L, Su C, et al. Luteolin protects against vascular calcification by modulating SIRT1/CXCR4 signaling pathway and promoting autophagy. AAPS J. 2024; 26(6):111. https://doi.org/10.1208/s12248—024—00982—y.

[170] Song Z, Wei D, Chen Y, et al. Association of astragaloside IV—inhibited autophagy and mineralization in vascular smooth muscle cells with lncRNA H19 and DUSP5—mediated ERK signaling. Toxicol Appl Pharmacol. 2019; 364:45-54. https://doi.org/10.1016/j.taap.2018.12.002.

[171] Liu Y, Song A, Wu H, et al. Paeonol inhibits apoptosis of vascular smooth muscle cells via up—regulation of autophagy by activating class III PI3K/Beclin—1 signaling pathway. Life Sci. 2021; 264:118714. https://doi.org/10.1016/j.lfs.2020.118714.

[172] Liang Y, Dong L, Yan J, et al. Paeonol attenuates atherosclerosis by regulating vascular smooth muscle cells apoptosis and modulating immune cells infiltration through reducing LTβR expression. Phytomedicine. 2024; 135:156196. https://doi.org/10.1016/j.phymed.2024.156196.

[173] Yang HL, Korivi M, Chen CH, et al. Antrodia camphorata attenuates cigarette smoke—induced ROS production, DNA damage, apoptosis, and inflammation in vascular smooth muscle cells, and atherosclerosis in ApoE—deficient mice. Environ Toxicol. 2017; 32(8):2070-2084. https://doi.org/10.1002/tox.22422.

[174] Yang H, Xu G, Li Q, et al. Ligustrazine alleviates the progression of coronary artery calcification by nhibiting caspase—3/GSDME mediated pyroptosis. Biosci Trends. 2024; 18(5):482-491. https://doi.org/10.5582/bst.2024.01096.

[175] Zhang J, Xie SA, Wang J, et al. Echinatin maintains glutathione homeostasis in vascular smooth muscle cells to protect against matrix remodeling and arterial stiffening. Matrix Biol. 2023; 119:1-18. https://doi.org/10.1016/j.matbio.2023.03.007.

[176] Zhang J, Yan J. Protective effect of ginkgolic acid in attenuating LDL induced inflammation human peripheral blood mononuclear cells via altering the NF—κB signaling pathway. Front Pharmacol. 2019; 10:1241. https://doi.org/10.3389/fphar.2019.01241.

[177] Förstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. 2017; 120(4):713-735. https://doi.org/10.1161/CIRCRESAHA.116.309326.

[178] Lee KP, Sudjarwo GW, Jung SH, et al. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells. Atherosclerosis. 2015; 240(2):367-373. https://doi.org/10.1016/j.atherosclerosis.2015.03.038.

[179] Wang YL, Sun gy, Zhang Y, et al. Tormentic acid inhibits H2O2—induced oxidative stress and inflammation in rat vascular smooth muscle cells via inhibition of the NF—κB signaling pathway. Mol Med Rep. 2016; 14(4):3559-3564. https://doi.org/10.3892/mmr.2016.5690.

[180] Hu Y, Li H, Li R, et al. Puerarin protects vascular smooth muscle cells from oxidized low—density lipoprotein—induced reductions in viability via inhibition of the p38 MAPK and JNK signaling pathways. Exp Ther Med. 2020; 20(6):270. https://doi.org/10.3892/etm.2020.9400.

[181] Zheng X, Wang P, Jia M, et al. Baicalin alleviates thrombin—induced inflammation in vascular smooth muscle cells. Biomed Res Int. 2022; 2022:5799308. https://doi.org/10.1155/2022/5799308.

[182] Zhang X, Qin Y, Ruan W, et al. Targeting inflammation—associated AMPK/Mfn—2/MAPKs signaling pathways by baicalein exerts anti—atherosclerotic action. Phytother Res. 2021; 35(8):4442-4455. https://doi.org/10.1002/ptr.7149.

[183] Meng L, Yan D, Xu W, et al. Emodin inhibits tumor necrosis factor—α—induced migration and inflammatory responses in rat aortic smooth muscle cells. Int J Mol Med. 2012; 29(6):999-1006. https://doi.org/10.3892/ijmm.2012.940.

[184] Li Y, Guo Y, Chen Y, et al. Establishment of an interleukin—1β—induced inflammation—activated endothelial cell—smooth muscle cell—mononuclear cell co—culture model and evaluation of the anti—inflammatory effects of tanshinone IIA on atherosclerosis. Mol Med Rep. 2015; 12(2):1665-1676. https://doi.org/10.3892/mmr.2015.3668.

[185] Quesada I, de Paola M, Alvarez MS, et al. Antioxidant and anti—atherogenic properties of Prosopis strombulifera and Tessaria absinthioides aqueous extracts: modulation of NADPH oxidase—derived reactive oxygen species. Front Physiol. 2021; 12:662833. https://doi.org/10.3389/fphys.2021.662833.

[186] Lee AS, Kim Y, Hur HJ, et al. Chrysanthemum coronarium L. extract attenuates homocysteine—induced vascular inflammation in vascular smooth muscle cells. J Med Food. 2023; 26(12):869-876. https://doi.org/10.1089/jmf.2023.K.0058.

[187] Wang YS, Lin RT, Cheng HY, et al. Anti—atherogenic effect of San—Huang—Xie—Xin—Tang, a traditional Chinese medicine, in cultured human aortic smooth muscle cells. J Ethnopharmacol. 2011; 133(2):442-447. https://doi.org/10.1016/j.jep.2010.10.018.

[188] Guo H, Li Y, Qiu L, et al. Gua—Lou Er—Chen Decoction attenuates atherosclerosis by reducing proteoglycans accumulation and inflammation. Phytomedicine. 2023; 115:154811. https://doi.org/10.1016/j.phymed.2023.154811.

[189] Wei JM, Yuan H, Liu CX, et al. The Chinese medicine Xin—Tong—Tai Granule protects atherosclerosis by regulating oxidative stress through NOX/ROS/NF—κB signal pathway. Biomed Pharmacother. 2023; 165:115200. https://doi.org/10.1016/j.biopha.2023.115200.

[190] Zhou J, Zhang L, Zheng B, et al. Salvia miltiorrhiza bunge exerts anti—oxidative effects through inhibiting KLF10 expression in vascular smooth muscle cells exposed to high glucose. J Ethnopharmacol. 2020; 262:113208. https://doi.org/10.1016/j.jep.2020.113208.

[191] Gong X, Liu Y, Liu H, et al. Re—analysis of single—cell transcriptomics reveals a critical role of macrophage—like smooth muscle cells in advanced atherosclerotic plaque. Theranostics. 2024; 14(4):1450-1463. https://doi.org/10.7150/thno.87201.

[192] Xue Y, Luo M, Hu X, et al. Macrophages regulate vascular smooth muscle cell function during atherosclerosis progression through IL—1β/STAT3 signaling. Commun Biol. 2022; 5(1):1316. https://doi.org/10.1038/s42003—022—04255—2.

[193] Adhikari N, Shekar KC, Staggs R, et al. Guidelines for the isolation and characterization of murine vascular smooth muscle cells. A report from the International Society of Cardiovascular Translational Research. J Cardiovasc Transl Res. 2015; 8(3):158-163. https://doi.org/10.1007/s12265—015—9616—6.

[194] Wang D, Yang Y, Lei Y, et al. Targeting foam cell formation in atherosclerosis: therapeutic potential of natural products. Pharmacol Rev. 2019; 71(4):596-670. https://doi.org/10.1124/pr.118.017178.

[195] Maguire EM, Pearce SWA, Xiao Q. Foam cell formation: a new target for fighting atherosclerosis and cardiovascular disease. Vascul Pharmacol. 2019; 112:54-71. https://doi.org/10.1016/j.vph.2018.08.002.

[196] Chistiakov DA, Melnichenko AA, Myasoedova VA, et al. Mechanisms of foam cell formation in atherosclerosis. J Mol Med (Berl). 2017; 95(11):1153-1165. https://doi.org/10.1007/s00109—017—1575—8.